EligibleTrials

Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia

Recruiting · NCT07060066 · Interventional (participants receive a specific treatment) · Lead sponsor: The University of Texas Health Science Center, Houston

View the official record on ClinicalTrials.gov →
DepressionSchizophrenia

Interventions studied

Active rTMS stimulationSham rTMS stimulation

What this trial is about

The purpose of this study is to provide an effective repetitive transcranial magnetic stimulation (rTMS) treatment for depressive symptoms in patients with schizophrenia. Schizophrenia patients with depressive symptoms will be exposed to rTMS to improve their symptoms.

Who can take part

Age range
18 Years to 60 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

2 locations listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.